North Shore InnoVentures, a technology incubator based in Beverly, said that six startup companies in the clean technology and life sciences sectors have joined its program over the last few months.
Among those startups is Lariat Biosciences, which is developing a non-invasive diagnostic to detect early signs of cancer based on circulating free DNA within the bloodstream.
Another is Apptomics, which is focused on mobile applications and devices designed to help patients, caregivers, and health care professionals better manage symptoms of neurological conditions.
“This is a record number of companies joining our incubator at once and is reflective of the improving business climate and continuing growth opportunities for startups in Massachusetts,” Martha Farmer, CEO of North Shore Innoventures, said in a statement. “Each of these companies has remarkably innovative technologies and the scientific and management teams that will prove crucial to their future commercial development. We look forward to helping with their success.”
A total of 21 companies are now in the North Shore InnoVentures program, which provides work space, cost savings, mentoring, and collaboration opportunities to its members.
North Shore InnoVentures is a nonprofit organization that is supported by state and federal grants as well as by corporate sponsors.